-
-
-
-
-
-
-
-
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Based on a post hoc analysis, a majority of participants (~70%) experienced clinically meaningful tic reduction within 8 weeks of starting ecopipam An interim 18-month analysis of an ongoing open...资讯2026-10-02
-
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ec The published review examines dopamine’s role in tic generation and how approved and investigational drugs may affect dopamine to reduce tics as well as synthesizes clinical trial evidence that e...资讯2026-10-02
-
-
-
最热